MORGAN STANLEY - ESPERION THERAPEUTICS INC NE ownership

ESPERION THERAPEUTICS INC NE's ticker is and the CUSIP is 29664WAB1. A total of 19 filers reported holding ESPERION THERAPEUTICS INC NE in Q4 2021. The put-call ratio across all filers is - and the average weighting 0.1%.

Quarter-by-quarter ownership
MORGAN STANLEY ownership history of ESPERION THERAPEUTICS INC NE
ValueSharesWeighting
Q3 2023$405,820
+5.8%
788,0000.0%0.00%
Q2 2023$383,677
+22.9%
788,0000.0%0.00%
Q1 2023$312,127
-76.3%
788,000
-69.6%
0.00%
Q4 2022$1,319,362
-0.6%
2,588,0000.0%0.00%
Q3 2022$1,327,000
-5.1%
2,588,0000.0%0.00%
Q2 2022$1,398,000
-32.0%
2,588,000
-36.0%
0.00%
Q1 2022$2,055,000
-43.3%
4,046,000
-42.6%
0.00%
Q4 2021$3,626,0007,046,0000.00%
Other shareholders
ESPERION THERAPEUTICS INC NE shareholders Q4 2021
NameSharesValueWeighting ↓
PenderFund Capital Management Ltd. 17,454,000$9,8263.09%
Affinity Asset Advisors, LLC 7,500,000$3,008,2500.99%
DCF Advisers, LLC 3,600,000$1,476,0000.90%
Context Capital Management, LLC 21,851$8,7640.74%
HIGHBRIDGE CAPITAL MANAGEMENT LLC 32,000,000$13,1200.48%
SILVERBACK ASSET MANAGEMENT LLC 6,250,000$2,500,0000.34%
WHITEBOX ADVISORS LLC 20,600,000$8,159,6600.28%
TENOR CAPITAL MANAGEMENT Co., L.P. 26,425,000$11,431,7480.23%
READYSTATE ASSET MANAGEMENT LP 5,500,000$2,206,0500.20%
DAVIDSON KEMPNER PARTNERS 25,000,000$9,432,5000.18%
View complete list of ESPERION THERAPEUTICS INC NE shareholders